BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24041884)

  • 1. Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.
    Morris CA; Tan B; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5889-900. PubMed ID: 24041884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
    Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
    PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
    Karunajeewa HA; Ilett KF; Dufall K; Kemiki A; Bockarie M; Alpers MP; Barrett PH; Vicini P; Davis TM
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2966-72. PubMed ID: 15273107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.
    Morris CA; Onyamboko MA; Capparelli E; Koch MA; Atibu J; Lokomba V; Douoguih M; Hemingway-Foday J; Wesche D; Ryder RW; Bose C; Wright L; Tshefu AK; Meshnick S; Fleckenstein L
    Malar J; 2011 May; 10():114. PubMed ID: 21548983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.
    Saunders D; Khemawoot P; Vanachayangkul P; Siripokasupkul R; Bethell D; Tyner S; Se Y; Rutvisuttinunt W; Sriwichai S; Chanthap L; Lin J; Timmermans A; Socheat D; Ringwald P; Noedl H; Smith B; Fukuda M; Teja-Isavadharm P
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5484-93. PubMed ID: 22869581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.
    Tan B; Naik H; Jang IJ; Yu KS; Kirsch LE; Shin CS; Craft JC; Fleckenstein L
    Malar J; 2009 Dec; 8():304. PubMed ID: 20021657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.
    Newton PN; Barnes KI; Smith PJ; Evans AC; Chierakul W; Ruangveerayuth R; White NJ
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1003-9. PubMed ID: 17089111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
    Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
    Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.
    Hendriksen IC; Mtove G; Kent A; Gesase S; Reyburn H; Lemnge MM; Lindegardh N; Day NP; von Seidlein L; White NJ; Dondorp AM; Tarning J
    Clin Pharmacol Ther; 2013 May; 93(5):443-50. PubMed ID: 23511715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.
    Morris CA; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
    Malar J; 2011 Sep; 10():263. PubMed ID: 21914160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.
    Ericsson T; Blank A; von Hagens C; Ashton M; Äbelö A
    Eur J Clin Pharmacol; 2014 Dec; 70(12):1453-63. PubMed ID: 25248945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.
    Nealon C; Dzeing A; Müller-Römer U; Planche T; Sinou V; Kombila M; Kremsner PG; Parzy D; Krishna S
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3933-9. PubMed ID: 12435698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy.
    Jullien V; Ogutu B; Juma E; Carn G; Obonyo C; Kiechel JR
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2611-7. PubMed ID: 20368402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients.
    Ayyoub A; Methaneethorn J; Ramharter M; Djimde AA; Tekete M; Duparc S; Borghini-Fuhrer I; Shin JS; Fleckenstein L
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1450-8. PubMed ID: 26666916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.
    McGready R; Phyo AP; Rijken MJ; Tarning J; Lindegardh N; Hanpithakpon W; Than HH; Hlaing N; Zin NT; Singhasivanon P; White NJ; Nosten F
    Br J Clin Pharmacol; 2012 Mar; 73(3):467-77. PubMed ID: 21950338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteers.
    Matar KM; Awad AI; Elamin SB
    Am J Trop Med Hyg; 2014 Jun; 90(6):1087-93. PubMed ID: 24615137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
    Miller AK; Bandyopadhyay N; Wootton DG; Duparc S; Kirby PL; Winstanley PA; Ward SA
    Eur J Clin Pharmacol; 2009 Oct; 65(10):977-87. PubMed ID: 19517101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria.
    Batty KT; Thu LT; Davis TM; Ilett KF; Mai TX; Hung NC; Tien NP; Powell SM; Thien HV; Binh TQ; Kim NV
    Br J Clin Pharmacol; 1998 Feb; 45(2):123-9. PubMed ID: 9491824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.